Hence, one potential explanation for the increased efficacy of tirzepatide on glycemic control relative to the monoagonist GLP-1RA is that targeting both incretin receptors maintains some insulinotropic activity even in subjects who are relatively insensitive to GLP-1
Spironolactone Sleep Impact and Optimization At a glance Drug class / aldosterone antagonist and potassium-sparing diuretic Common sleep-related complaint / nocturia (nighttime urination) reported in 10 to 30% of users Primary mechanism of sleep disruption / diuresis peaking 3 to 6 hours post-dose Dose range for acne and hirsutism / 50 to 200 mg per day (oral) Best dosing window to protect sleep / morning, ideally before 10 a.m
Otherwise, vitamin supplements are cheaper and safer than nootropics
Topical creams and gels are the least effective form of glutathione
This question represents one of the major pain points for those who experience GLP-1 hair loss
The mechanisms of BBB disruption in MS may include direct effects of cytokines, including IL-17 and TNF from infiltrating T cells, and intrinsic endothelial abnormalities